Abstract
Adaptive trials allow modifications to the trial design following initiation of the trial, and are of particular interest for research in oncology, increasing trial flexibility, efficiency, and the speed at which novel therapies can be evaluated. This study aimed to identify the likelihood for oncology therapies, investigated via adaptive trial designs, to obtain regulatory approval and positive HTA recommendations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
